# Southland Holdings, Inc.: financial statements, quarterly

SLND · NYSE · CIK 1883814 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/slnd.md) · [Financials](/companies/slnd/financials.md) · [Filings](/companies/slnd/filings.md) · [Insiders](/companies/slnd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/slnd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [312](/filings/0001558370-24-015346.md) | [316 d](/filings/0001104659-26-035302.md) | [288](/filings/0001558370-25-007594.md) | [252](/filings/0001558370-25-011241.md) | [173](/filings/0001104659-25-110523.md) | [267 d](/filings/0001104659-26-035302.md) | [239](/filings/0001104659-26-059468.md) | [215](/filings/0001104659-26-095036.md) | [213](/filings/0001104659-25-110523.md) | [104 d](/filings/0001104659-26-035302.md) | [172](/filings/0001104659-26-059468.md) | [113](/filings/0001104659-26-095036.md) |
| Cost of revenue | $m | [283](/filings/0001558370-24-015346.md) | [295 d](/filings/0001104659-26-035302.md) | [268](/filings/0001558370-25-007594.md) | [292](/filings/0001558370-25-011241.md) | [224](/filings/0001104659-25-110523.md) | [260 d](/filings/0001104659-26-035302.md) | [218](/filings/0001104659-26-059468.md) | [202](/filings/0001104659-26-095036.md) | [210](/filings/0001104659-25-110523.md) | [297 d](/filings/0001104659-26-035302.md) | [177](/filings/0001104659-26-059468.md) | [185](/filings/0001104659-26-095036.md) |
| Gross profit | $m | [29.5](/filings/0001558370-24-015346.md) | [21.1 d](/filings/0001104659-26-035302.md) | [20.4](/filings/0001558370-25-007594.md) | [(40.0)](/filings/0001558370-25-011241.md) | [(51.1)](/filings/0001104659-25-110523.md) | [7.7 d](/filings/0001104659-26-035302.md) | [21.5](/filings/0001104659-26-059468.md) | [13.0](/filings/0001104659-26-095036.md) | [3.3](/filings/0001104659-25-110523.md) | [(193) d](/filings/0001104659-26-035302.md) | [(4.8)](/filings/0001104659-26-059468.md) | [(71.2)](/filings/0001104659-26-095036.md) |
| Selling, general and administrative | $m | [15.2](/filings/0001558370-24-015346.md) | [19.9 d](/filings/0001104659-26-035302.md) | [14.4](/filings/0001558370-25-007594.md) | [15.7](/filings/0001558370-25-011241.md) | [17.5](/filings/0001104659-25-110523.md) | [15.7 d](/filings/0001104659-26-035302.md) | [16.5](/filings/0001104659-26-059468.md) | [13.6](/filings/0001104659-26-095036.md) | [14.6](/filings/0001104659-25-110523.md) | [17.0 d](/filings/0001104659-26-035302.md) | [14.9](/filings/0001104659-26-059468.md) | [16.7](/filings/0001104659-26-095036.md) |
| Operating income | $m | [14.3](/filings/0001558370-24-015346.md) | [1.2 d](/filings/0001104659-26-035302.md) | [6.0](/filings/0001558370-25-007594.md) | [(55.7)](/filings/0001558370-25-011241.md) | [(68.6)](/filings/0001104659-25-110523.md) | [(8.0) d](/filings/0001104659-26-035302.md) | [5.0](/filings/0001104659-26-059468.md) | [(0.6)](/filings/0001104659-26-095036.md) | [(11.3)](/filings/0001104659-25-110523.md) | [(210) d](/filings/0001104659-26-035302.md) | [(19.7)](/filings/0001104659-26-059468.md) | [(87.9)](/filings/0001104659-26-095036.md) |
| Interest expense | $m | [6.2](/filings/0001558370-23-018856.md) | [5.7 d](/filings/0001558370-24-002367.md) | [5.7](/filings/0001558370-24-007986.md) | [6.7](/filings/0001558370-25-011241.md) | [7.5](/filings/0001104659-25-110523.md) | [9.6 d](/filings/0001104659-26-035302.md) | [8.9](/filings/0001104659-26-059468.md) | [10.0](/filings/0001104659-26-095036.md) | [9.2](/filings/0001104659-25-110523.md) | [9.0 d](/filings/0001104659-26-035302.md) | [8.7](/filings/0001104659-26-059468.md) | [7.3](/filings/0001104659-26-095036.md) |
| Income tax | $m | [5.4](/filings/0001558370-24-015346.md) | [2.9 d](/filings/0001104659-26-035302.md) | [0.3](/filings/0001558370-25-007594.md) | [(16.0)](/filings/0001558370-25-011241.md) | [(17.1)](/filings/0001104659-25-110523.md) | [(14.1) d](/filings/0001104659-26-035302.md) | [(0.3)](/filings/0001104659-26-059468.md) | [(0.1)](/filings/0001104659-26-095036.md) | [57.2](/filings/0001104659-25-110523.md) | [(0.3) d](/filings/0001104659-26-035302.md) | [0.0](/filings/0001104659-26-059468.md) | [(1.6)](/filings/0001104659-26-095036.md) |
| Net income | $m | [3.8](/filings/0001558370-24-015346.md) | [(5.6) d](/filings/0001104659-26-035302.md) | [(0.4)](/filings/0001558370-25-007594.md) | [(46.1)](/filings/0001558370-25-011241.md) | [(54.7)](/filings/0001104659-25-110523.md) | [(4.2) d](/filings/0001104659-26-035302.md) | [(4.6)](/filings/0001104659-26-059468.md) | [(10.3)](/filings/0001104659-26-095036.md) | [(75.3)](/filings/0001104659-25-110523.md) | [(216) d](/filings/0001104659-26-035302.md) | [(28.4)](/filings/0001104659-26-059468.md) | [(84.3)](/filings/0001104659-26-095036.md) |
| Diluted EPS | $ per share | [0.08](/filings/0001558370-24-015346.md) | not reported | [(0.01)](/filings/0001558370-25-007594.md) | [(0.96)](/filings/0001558370-25-011241.md) | [(1.14)](/filings/0001104659-25-110523.md) | not reported | [(0.08)](/filings/0001104659-26-059468.md) | [(0.19)](/filings/0001104659-26-095036.md) | [(1.39)](/filings/0001104659-25-110523.md) | not reported | [(0.52)](/filings/0001104659-26-059468.md) | [(1.55)](/filings/0001104659-26-095036.md) |
| Basic EPS | $ per share | [0.08](/filings/0001558370-24-015346.md) | not reported | [(0.01)](/filings/0001558370-25-007594.md) | [(0.96)](/filings/0001558370-25-011241.md) | [(1.14)](/filings/0001104659-25-110523.md) | not reported | [(0.08)](/filings/0001104659-26-059468.md) | [(0.19)](/filings/0001104659-26-095036.md) | [(1.39)](/filings/0001104659-25-110523.md) | not reported | [(0.52)](/filings/0001104659-26-059468.md) | [(1.55)](/filings/0001104659-26-095036.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [32.2](/filings/0001558370-23-018856.md) | [49.2](/filings/0001104659-26-035302.md) | [31.2](/filings/0001558370-24-007986.md) | [52.4](/filings/0001558370-24-011946.md) | [91.4](/filings/0001558370-24-015346.md) | [72.2](/filings/0001104659-26-095036.md) | [65.1](/filings/0001558370-25-007594.md) | [46.5](/filings/0001558370-25-011241.md) | [40.5](/filings/0001104659-25-110523.md) | [52.7](/filings/0001104659-26-095036.md) | [20.5](/filings/0001104659-26-059468.md) | [34.9](/filings/0001104659-26-095036.md) |
| Current assets | $m | [909](/filings/0001558370-23-018856.md) | [943](/filings/0001558370-25-002183.md) | [967](/filings/0001558370-24-007986.md) | [981](/filings/0001558370-24-011946.md) | [884](/filings/0001558370-24-015346.md) | [882](/filings/0001104659-26-035302.md) | [885](/filings/0001558370-25-007594.md) | [867](/filings/0001558370-25-011241.md) | [870](/filings/0001104659-25-110523.md) | [734](/filings/0001104659-26-095036.md) | [679](/filings/0001104659-26-059468.md) | [547](/filings/0001104659-26-095036.md) |
| Total assets | $m | [1,180](/filings/0001558370-23-018856.md) | [1,201](/filings/0001558370-25-002183.md) | [1,227](/filings/0001558370-24-007986.md) | [1,263](/filings/0001558370-24-011946.md) | [1,187](/filings/0001558370-24-015346.md) | [1,204](/filings/0001104659-26-035302.md) | [1,203](/filings/0001558370-25-007594.md) | [1,185](/filings/0001558370-25-011241.md) | [1,136](/filings/0001104659-25-110523.md) | [989](/filings/0001104659-26-095036.md) | [928](/filings/0001104659-26-059468.md) | [785](/filings/0001104659-26-095036.md) |
| Current liabilities | $m | [548](/filings/0001558370-23-018856.md) | [584](/filings/0001558370-25-002183.md) | [606](/filings/0001558370-24-007986.md) | [770](/filings/0001558370-24-011946.md) | [598](/filings/0001558370-24-015346.md) | [621](/filings/0001104659-26-035302.md) | [638](/filings/0001558370-25-007594.md) | [637](/filings/0001558370-25-011241.md) | [672](/filings/0001104659-25-110523.md) | [655](/filings/0001104659-26-095036.md) | [527](/filings/0001104659-26-059468.md) | [429](/filings/0001104659-26-095036.md) |
| Total liabilities | $m | [914](/filings/0001558370-23-018856.md) | [941](/filings/0001558370-25-002183.md) | [966](/filings/0001558370-24-007986.md) | [1,048](/filings/0001558370-24-011946.md) | [1,029](/filings/0001558370-24-015346.md) | [1,028](/filings/0001104659-26-035302.md) | [1,030](/filings/0001558370-25-007594.md) | [1,020](/filings/0001558370-25-011241.md) | [1,049](/filings/0001104659-25-110523.md) | [1,122](/filings/0001104659-26-095036.md) | [1,089](/filings/0001104659-26-059468.md) | [1,033](/filings/0001104659-26-095036.md) |
| Long-term debt | $m | [261](/filings/0001558370-23-018856.md) | [252](/filings/0001558370-25-002183.md) | [256](/filings/0001558370-24-007986.md) | [173](/filings/0001558370-24-011946.md) | [275](/filings/0001558370-24-015346.md) | [256](/filings/0001104659-26-035302.md) | [241](/filings/0001558370-25-007594.md) | [230](/filings/0001558370-25-011241.md) | [216](/filings/0001104659-25-110523.md) | [204](/filings/0001104659-26-095036.md) | [175](/filings/0001104659-26-059468.md) | [149](/filings/0001104659-26-095036.md) |
| Current portion of debt | $m | [47.8](/filings/0001558370-23-018856.md) | [48.5](/filings/0001558370-25-002183.md) | [46.4](/filings/0001558370-24-007986.md) | [135](/filings/0001558370-24-011946.md) | [43.1](/filings/0001558370-24-015346.md) | [44.5](/filings/0001104659-26-035302.md) | [46.8](/filings/0001558370-25-007594.md) | [48.9](/filings/0001558370-25-011241.md) | [51.4](/filings/0001104659-25-110523.md) | [53.7](/filings/0001104659-26-095036.md) | [56.1](/filings/0001104659-26-059468.md) | [58.0](/filings/0001104659-26-095036.md) |
| Shareholders' equity | $m | [254](/filings/0001558370-23-018856.md) | [250](/filings/0001558370-25-002183.md) | [249](/filings/0001558370-24-007986.md) | [203](/filings/0001558370-24-011946.md) | [149](/filings/0001558370-24-015346.md) | [164](/filings/0001104659-26-035302.md) | [159](/filings/0001558370-25-007594.md) | [151](/filings/0001558370-25-011241.md) | [75.0](/filings/0001104659-25-110523.md) | [(141)](/filings/0001104659-26-095036.md) | [(169)](/filings/0001104659-26-059468.md) | [(254)](/filings/0001104659-26-095036.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(26.0) d](/filings/0001558370-24-015346.md) | [26.3 d](/filings/0001104659-26-035302.md) | [(9.9)](/filings/0001558370-25-007594.md) | [27.4 d](/filings/0001558370-25-011241.md) | [(5.3) d](/filings/0001104659-25-110523.md) | [(10.3) d](/filings/0001104659-26-035302.md) | [6.4](/filings/0001104659-26-059468.md) | [(5.4) d](/filings/0001104659-26-095036.md) | [5.9 d](/filings/0001104659-25-110523.md) | [9.7 d](/filings/0001104659-26-035302.md) | [(134)](/filings/0001104659-26-059468.md) | [(38.0) d](/filings/0001104659-26-095036.md) |
| Capital expenditure | $m | [2.5 d](/filings/0001558370-24-015346.md) | [3.4 d](/filings/0001104659-26-035302.md) | [3.1](/filings/0001558370-25-007594.md) | [1.1 d](/filings/0001558370-25-011241.md) | [2.0 d](/filings/0001104659-25-110523.md) | [1.2 d](/filings/0001104659-26-035302.md) | [1.8](/filings/0001104659-26-059468.md) | [1.1 d](/filings/0001104659-26-095036.md) | [0.6 d](/filings/0001104659-25-110523.md) | [0.4 d](/filings/0001104659-26-035302.md) | [0.0](/filings/0001104659-26-059468.md) | [0.4 d](/filings/0001104659-26-095036.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [44.4](/filings/0001558370-24-007986.md) | [46.9](/filings/0001558370-24-011946.md) | [47.9](/filings/0001558370-24-015346.md) | [47.9](/filings/0001558370-25-007594.md) | [48.0](/filings/0001558370-25-011241.md) | [48.1](/filings/0001104659-25-110523.md) | [54.0](/filings/0001104659-26-059468.md) | [54.0](/filings/0001104659-26-095036.md) | [54.1](/filings/0001104659-25-110523.md) | [54.1](/filings/0001104659-26-059468.md) | [54.2](/filings/0001104659-26-095036.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 54,435,257 at 2026-08-04, from the cover of the [10-Q filed 2026-08-12](/filings/0001104659-26-095036.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.